Copyright
©The Author(s) 2018.
World J Cardiol. Oct 26, 2018; 10(10): 145-152
Published online Oct 26, 2018. doi: 10.4330/wjc.v10.i10.145
Published online Oct 26, 2018. doi: 10.4330/wjc.v10.i10.145
Table 1 Baseline characteristics of our seven patients
Patient A | Patient B | Patient C | Patient D | Patient E | Patient F | Patient G | All patients | |
Sex | Male | Male | Male | Male | Male | Male | Male | All male (100%) |
Age (yr) | 89 | 72 | 55 | 67 | 85 | 67 | 80 | 74 ± 11 |
Cardiovascular risk factors | Hypertension | Hypertension | Hypertension | Hypertension | Hypertension | Hypertension | Hypertension | Hypertension (100%) |
Hyperlipidemia | Hyperlipidemia | Hyperlipidemia | Hyperlipidemia | Hyperlipidemia | Hyperlipidemia | Hyperlipidemia | Hyperlipidemia (100%) | |
Type 2 DM | Type 2 DM | Type 2 DM | Smoking | Type 2 DM | Smoking | Type 2 DM (57%) | ||
Smoking | Smoking (43%) | |||||||
PAD history | No | Surgical endatherectomy of the left common femoral artery 2012 | No | Prior Angioplasty and stent placement in the left popliteal artery 2015 | No | Prior Angioplasty and stent placement in the left popliteal artery 2016 | No | 3/7 (43%) |
LV function | Moderately reduced | Normal | Normal | Normal | Severely reduced | Mildly reduced | Normal | Reduced in 3/7 (43%) |
Symptoms onset | For 12 h | For 16 h | For 2 h | For 12 h | For 36 h | For 6 h | For 36 h | 17 ± 13 |
CAD history | 3 vessel CAD | 3 vessel CAD | No | 3 vessel CAD | 3 vessel CAD | 3 vessel CAD | 3 vessel CAD | 6/7 (86%) |
GABG 2005 | ||||||||
Baseline medication | Aspirin | Aspirin | Aspirin | Aspirin | Aspirin | Aspirin | Aspirin | Aspirin (100%) |
ß-blocker | ß-blocker | ACE inhibitor | ß-blocker | ß-blocker | ß-blocker | ß-blocker | ß-blocker (86%) | |
ACE inhibitor | ACE inhibitor | Statin | ACE inhibitor | ACE inhibitor | ACE inhibitor | ACE inhibitor | ACE inhibitor 100%) | |
Statin | Statin | Statin | Statin | Statin | Statin | Statin (100%) | ||
Diuretics | Diuretics | Diuretics | Diuretics | Diuretics (57%) | ||||
Other comorbidities | Reduced renal function with estimated GFR of -40 mL/min/1.73 m² | Reduced renal function with estimated GFR of -50 mL/min/1.73 m² | None | Reduced renal function with estimated GFR of -45 mL/min/1.73 m² | Reduced renal function with estimated GFR of -55 mL/min/1.73 m² | Reduced renal function with estimated GFR of -50 mL/min/1.73 m² | Reduced renal function with estimated GFR of -40 mL/min/1.73 m² | Reduced renal function (86%) |
Atrial fibrillation | Atrial fibrillation | Atrial fibrillation | Atrial fibrillation | Atrial fibrillation | Atrial fibrillation (71%) | |||
Heart failure | Heart failure NYHA III | Heart failure NYHA II | Heart failure (43%) | |||||
NYHA III |
- Citation: Giusca S, Raupp D, Dreyer D, Eisenbach C, Korosoglou G. Successful endovascular treatment in patients with acute thromboembolic ischemia of the lower limb including the crural arteries. World J Cardiol 2018; 10(10): 145-152
- URL: https://www.wjgnet.com/1949-8462/full/v10/i10/145.htm
- DOI: https://dx.doi.org/10.4330/wjc.v10.i10.145